Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ralph Gruppo
Perioperative Haemostasis With Full‐length, PEGylated, Recombinant Factor VIII With Extended Half‐life (Rurioctocog Alfa Pegol) in Patients With Haemophilia A: Final Results of a Multicentre, Single‐arm Phase III Trial
Haemophilia
Medicine
Genetics
Hematology
Mutations in a Member of the ADAMTS Gene Family Cause Thrombotic Thrombocytopenic Purpura
Nature
Multidisciplinary
Related publications
Successful Haemostasis With Extended Half-Life Recombinant Factor VIII in Circumcision
Turkish Journal of Haematology
Hematology
Desmopressin Treatment Combined With Clotting Factor VIII Concentrates in Patients With Non-Severe Haemophilia A: Protocol for a Multicentre Single-Armed Trial, the DAVID Study
BMJ Open
Medicine
Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation Alone in Resected Stage III Melanoma: Final Results of EORTC 18991, a Randomised Phase III Trial
The Lancet
Medicine
Postmarketing Safety and Effectiveness of Recombinant Factor IX (Nonacog Alfa) in Japanese Patients With Haemophilia B
Haemophilia
Medicine
Genetics
Hematology
Real-World Health Care Expenditure in Hemophilia a Patients Using Standard and Extended Half-Life Recombinant Factor VIII Products
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Highly Purified Porcine Factor VIII in Haemophilia a With Inhibitors to Factor VIII
BMJ
Tocilizumab in Patients With Anti-TNF Refractory Juvenile Idiopathic Arthritis-Associated Uveitis (APTITUDE): A Multicentre, Single-Arm, Phase 2 Trial
Lancet Rheumatology, The
Rheumatology
Allergy
Immunology
Turoctocog Alfa Pegol Provides Effective Management for Major and Minor Surgical Procedures in Patients Across All Age Groups With Severe Haemophilia A: Full Data Set From the Pathfinder 3 and 5 Phase III Trials
Haemophilia
Medicine
Genetics
Hematology
Immune Status of Patients With Haemophilia a Before Exposure to Factor VIII: First Results From the HEMFIL Study
British Journal of Haematology
Hematology
